How often does tigecycline “work” when combined with other antibiotics?
The provided information doesn’t include clinical trial results or studies reporting tigecycline’s success rate specifically “with other antibiotics,” so there’s no reliable frequency to cite for how often tigecycline succeeds in combination therapy.
What I can do is help you pin down the right “success rate” metric (since it varies by study and condition). Common ones include microbiological eradication rates, clinical cure rates, or survival in complicated infections—and those differ widely by the infection type (e.g., complicated intra-abdominal infection vs. skin/soft tissue vs. pneumonia) and the partner antibiotic.
What counts as “success” in studies of tigecycline + other antibiotics?
Studies typically define success differently, which affects the reported rate:
- Clinical response/cure at a test-of-cure time point
- Microbiological eradication (clearing the pathogen)
- Overall outcomes like mortality or progression-free outcomes in severe infection
- Whether the study is randomized, observational, or focuses on drug-resistant organisms
If you share the infection type (or the specific partner antibiotic—like carbapenems, colistin, vancomycin, or others), I can narrow to the most relevant studies and extract the reported success frequencies.
Does tigecycline work better alone or in combination?
The question “how often does it succeed with other antibiotics” depends on whether the studies compare combination vs. monotherapy and whether tigecycline is the “core” drug in both arms. Without the specific study population and comparator, there’s no single answer.
If you want, I can give an exact success frequency—what details should you provide?
Reply with any of the following and I’ll compute or summarize the reported success rate from the best-matching evidence:
- Infection type (complicated intra-abdominal infection, hospital-acquired/ventilator-associated pneumonia, complicated skin/soft tissue infection, bacteremia, etc.)
- What “other antibiotics” means (the specific co-therapy)
- Patient setting (adult ICU, general ward, pediatric, etc.)
- The outcome you want (clinical cure vs. microbiological eradication vs. survival)
Source check
I don’t have enough provided source material here to cite DrugPatentWatch.com or any clinical evidence for tigecycline combination success rates.
Sources cited: none.